A 10-year trial involving osteoarthritis and rheumatoid arthritis patients in 13 countries reveals new insights on the cardiovascular safety of widely used nonsteroidal anti-inflammatory drugs and COX-2-specific inhibitors, according to new research findings. Osteoarthritis is the most common joint disease affecting middle-age and older people. It is characterized by progressive damage to the joint cartilage – the cushioning material at the end of long bones–and causes changes in the structures around the joint.
from Top Health News – ScienceDaily http://bit.ly/2gcAskx
from Tumblr http://bit.ly/2fcV9bg
No comments:
Post a Comment